{"name":"Can-Fite BioPharma","slug":"can-fite-biopharma","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"CF102","genericName":"CF102","slug":"cf102","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"CF102","genericName":"CF102","slug":"cf102","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxOYlBxWDVFVmk0OHViRE5ZdkxRR0tndXZwdk9IUHViOUtCTW00ZXhwaFNMbmRvZGtmSlk4Mk1MMGUxSmh5NkxDNVJpZDVzd1pRdW80R3pGTnRBMWVielRTaXBXcDNHcEVNWGZFV3RQTGx3YmdIVHczVG9rTnE5WU5TMlcxQjlsMWNXeTg0T1RVeWZqbDFUalVFUVlHemxCUTRJS3R5azk0Y2xGcFBSZ0FHa1d3OWp5OHpuX2JUVzUweWNsVzIyS3dBX2JsWQ?oc=5","date":"2026-04-03","type":"pipeline","source":"Stock Titan","summary":"Can-Fite (CANF) registers resale of 1,647,449 ADSs tied to repriced warrants - Stock Titan","headline":"Can-Fite (CANF) registers resale of 1,647,449 ADSs tied to repriced warrants","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxPRzlBTGxVN282aU1XOHpMSC0tLTBEcFJ0aENmQzhINVV3ZE5SQXJfZXlMV0JFZl9iSFpRZWxJUFRlOUZqZ2FRZF9WR244V0lJRXM5X0oxRVhzWDdrR1ZjRHBZRVlRdjNoSTdaLTRyUEpqZDZoU0EwNi1ad0xnVG1GRGJVa1VQRVZyb1FHMWpzMXRwZzV4YUxOU3JvbkJHM1NZN29IWDZkUWliMWwzWUxsZ0xSa2kxdWtzVGNn?oc=5","date":"2026-03-30","type":"pipeline","source":"Stock Titan","summary":"[6-K] Can-Fite BioPharma Ltd. Current Report (Foreign Issuer) | CANF SEC Filing - Form 6-K - Stock Titan","headline":"[6-K] Can-Fite BioPharma Ltd. Current Report (Foreign Issuer) | CANF SEC Filing - Form 6-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxPRnZJSkZwRVJoX0k2eFd1QldWWlRGQ2p6dEt4TU51UGh5ZGQ1QkRTZ0htNFlScG5DY0I0OUVpN3U3Nm93VGVTMmJBUURmLWdLWlE4WVFaT1FmUnN2ZlBCVDl3VjFLUDNrakh2Wk9ULXQzbktsazd4dldRNktodmdNZ281dVV5cEtQbDc1X1NGWG0ycXJhZ3RfXzhTSm9KMFV5blZIXzVrWWNBSVhpSUhwYlQxNUhWMDYtLU1Z?oc=5","date":"2026-03-26","type":"trial","source":"Stock Titan","summary":"Can-Fite (NYSE: CANF) reports 2025 loss and promising liver cancer data - Stock Titan","headline":"Can-Fite (NYSE: CANF) reports 2025 loss and promising liver cancer data","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNQlZscEI1Vm9TakhHTDJUb05WcEFtMGJmYnhZbG5mNC01YWJWMUVKODVGVDgzWlZ2MUNGVFgwSTl1SkJaejIzMUtMZlpwR0NJaVhLX0luZGZ4VlQ4ZDdLeHh0VjdwaDNKMllOSlpvTUNNS255SWJNNllNYWtvZW5LOHVBb3RVTkpVU0YyWlk0SWJKZVdRcnlpMWlKUQ?oc=5","date":"2026-03-05","type":"trial","source":"Finviz","summary":"CANF Stock Soars 20% on Positive Mid-Stage Pancreatic Cancer Data - Finviz","headline":"CANF Stock Soars 20% on Positive Mid-Stage Pancreatic Cancer Data","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxQemxjQU1oY3lyS2hVSW5XM09jcjhEWWlXQ0FGdjNCWTJObnFRQ1FwbGNQYUNIUXpWVTNnNl9MZTNqRGlzOXhIT2NCeC1OQWpMMVMybDZSOVBVekZEZzhHS2NuTmMxV2dETWpBRVczQUsweng5VGRTOWRKNFZ4eWJwVGcyM0dMWEhCR1RzVUZjRzkzUEN6c1p1MTQ1M29aWEY1cl9MekN2NWw4S3FvSlVURHVyV3I?oc=5","date":"2026-03-05","type":"pipeline","source":"Benzinga","summary":"12 Health Care Stocks Moving In Thursday's Intraday Session - Can Fite Biopharma (AMEX:CANF), Gossamer Bi - Benzinga","headline":"12 Health Care Stocks Moving In Thursday's Intraday Session - Can Fite Biopharma (AMEX:CANF), Gossamer Bi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxOR1hxdTlDMHhuQkd2TzhYaEhkZk8tdFhhT19UVjJmWmxCWV85RElmR1RXUW9ZTEJ1TzQ5YXVjMFRDaXk0M2h6RzNKeV9ZTElxek5WYjFNRWEtTEdJUkVzQmpMRFVRamd3SHVRTnhVTWhuWUtHdElja2g0Mk5tSFJkMFktM3lVcVQ2OFZYVlg3NWwxSWRJMXdaMVFKakkyVjdIal9BSEpIUnZlSFFUeF9mMzBZZFRqRGts?oc=5","date":"2026-03-04","type":"pipeline","source":"Benzinga","summary":"12 Health Care Stocks Moving In Wednesday's Pre-Market Session - 20/20 Biolabs (NASDAQ:AIDX), Can Fite Bi - Benzinga","headline":"12 Health Care Stocks Moving In Wednesday's Pre-Market Session - 20/20 Biolabs (NASDAQ:AIDX), Can Fite Bi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxQUWlRS1VTLW9lbjBCbVFzQnJTX3RuMi1URHZWSDFRU0VGTFQ0cXc0OHpVOWd5c19YLUF1Smprb21fdVNNVnVEdllnQXBmamFHQWtqZDMyYy1jR2FNTkhSWDByS1FwOEdNOVlwbEh6VnFwRi03cy03ODlhc1hvdDM2SEw4S0l6aHhiQnNmTng5a0NOMWJrRko0LTdXaFRldkV3Y3pYR3FsZnlwbktYblBSSG5STTdmZjFRRHJV?oc=5","date":"2026-03-03","type":"pipeline","source":"Stock Titan","summary":"Can-Fite BioPharma (CANF) adjourns special shareholder meeting to March 10, 2026 - Stock Titan","headline":"Can-Fite BioPharma (CANF) adjourns special shareholder meeting to March 10, 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxPSGZGTm1vX01fTDFGUTRsX2NNVlA4cHh6cUFpMjZOYlNLYzZiOVJaaUFiTXQxNTBVVER5aC0tc0JBTjB3YzFxTjY0LTVtcWFaY1FNdHFEcDNlQmo2WTlhOUZBNHdHLVJ6M3B4dFZRbEpoR1BDRDI3NmJtZUZVaUVvR1dYdFcxdzNiYXJGRlJPa3BHcXYtYVA1Y2JwZkJib2RyUThxdW5uSjZLQW8zeG1pWU15ZHFLVXd0YkxnLVdzYk02anNMUVRhdHFKQmY1ZTFmMy1LVQ?oc=5","date":"2025-12-26","type":"patent","source":"Stocktwits","summary":"Can-Fite BioPharma Shares Surged 50% In Pre-Market On Brazilian Patent Win - Stocktwits","headline":"Can-Fite BioPharma Shares Surged 50% In Pre-Market On Brazilian Patent Win","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxPLVJ1dWxqbjAxTjd3TmMzZnM5dFlkbHF4d1ZfbmJ0ckZna0d5TlFJbGtXVWFNV0pjbTNjcEhVRFFFWE9ZX3NSYmk0bkVDRS1FQmVXU0FSTG0wUUNhNkZZMFVKX3BsTWRIVUdoU0ZnMUpXdmVwT1VxWU54X1A0dWg2QTJFdE9UWGZhRU81LTREUmZZdzJPLVhUN3NIb2Y4eC05UXFJUEQ1M2I0dFhlM3NSbzFsdEI1S0RScWg2N2tKYmt5RjQ?oc=5","date":"2025-12-24","type":"pipeline","source":"Benzinga","summary":"UiPath, Ramaco Resources And 3 Stocks To Watch Heading Into Wednesday - Citius Pharmaceuticals (NASDAQ:CT - Benzinga","headline":"UiPath, Ramaco Resources And 3 Stocks To Watch Heading Into Wednesday - Citius Pharmaceuticals (NASDAQ:CT","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPMTdXQUZKbU1tUEd3UHpCWHd6ZUVkanZNVHBoMnRvNWFyVGQtd2F5bEdQYkZRM3hRbUVNeUpNR1l6NGRpaDlhNk9SelREQ01RcktCeTBJV2NEXzRrY3EydUEwcmx6X3lxdHVhQ1daaTBhUDNzSENDSjBLRUVEcjZOX1ZHdUdIakdqZnk4R3oyb1YzNGF1VmJ6MG9ablJtZzg?oc=5","date":"2021-03-16","type":"pipeline","source":"InvestorPlace","summary":"CANF Stock: Why Are Can-Fite Biopharma Shares Skyrocketing Today? - InvestorPlace","headline":"CANF Stock: Why Are Can-Fite Biopharma Shares Skyrocketing Today?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE9UVTFleEJ3bGZYbHVPU1U1U2J2MTN1TDAzdnNaOVljeDg3QkJRbHRqQ3FiaF9YSGpYVWlWQkhLaHpSclpVbVBiRFNzUFFRUUdQdVpsaXFId3VxLW4wXzhqTk5JZGo5azRMTXJSdU1KTG1Rc2gtVU1Z?oc=5","date":"2019-08-04","type":"pipeline","source":"CTech","summary":"Can-Fite BioPharma Signs South Korean Distribution Agreement for Psoriasis Treatment Drug - CTech","headline":"Can-Fite BioPharma Signs South Korean Distribution Agreement for Psoriasis Treatment Drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxOa3ZxSUxUN1o4aGR6WmtPd3I3LUNaMThtaDVXcUI3dFFoZDZFSWcwZGI4Zl82b0pKOVdkOWs4cC13U1Z1VVJSYXRtcW9IRFdUOU1XXzRSRE1iRjlUbmhaVE8zRlgxMUV1R0x3UWhlNGl0cGtjNlRfYTA4OWVoY3BDeXdDNnVDczF4ZXhhYTR6bUlTM3hHSkh4c1otN3V3YURZYUp3d00yeG16X0FWc2pla0hwNUROZlhpRDd1b2J4VjZtV1pyOFE?oc=5","date":"2019-03-26","type":"trial","source":"Fierce Biotech","summary":"After a delay, Can-Fite digs into subpopulation data as liver cancer drug fails to hit primary endpoint - Fierce Biotech","headline":"After a delay, Can-Fite digs into subpopulation data as liver cancer drug fails to hit primary endpoint","sentiment":"negative"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}